Close Menu

NEW YORK — Italian oncology genetics company Impact Lab Group said on Tuesday that it has agreed to acquire HeartGenetics, a developer of bioinformatic software and personalized genetic tests.

Cantanhede, Portugal-based HeartGenetics offers a range of genetic tests and services including ones for general wellness, cardiovascular conditions including hereditary thrombophilia and hypertrophic cardiomyopathy, and pharmacogenetics. Impact said the acquisition will broaden its portfolio of test panels and expand its presence in Spain, Portugal, and South America.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.

Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.